BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11470147)

  • 21. On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201.
    Ploski R; Ek J; Thorsby E; Sollid LM
    Tissue Antigens; 1993 Apr; 41(4):173-7. PubMed ID: 8362409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan.
    Lu LY; Ding WZ; Fici D; Deulofeut R; Cheng HH; Cheu CC; Sung PK; Schur PH; Fraser PA
    Arthritis Rheum; 1997 Jun; 40(6):1138-45. PubMed ID: 9182925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DR and -DQ polymorphism in Cameroon.
    Pimtanothai N; Hurley CK; Leke R; Klitz W; Johnson AH
    Tissue Antigens; 2001 Jul; 58(1):1-8. PubMed ID: 11580849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class II DNA polymorphism in a Moroccan population from the Souss, Agadir area.
    Izaabel H; Garchon HJ; Caillat-Zucman S; Beaurain G; Akhayat O; Bach JF; Sanchez-Mazas A
    Tissue Antigens; 1998 Jan; 51(1):106-10. PubMed ID: 9459511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.
    Haegert DG; Swift FV; Benedikz J
    Neurology; 1996 Apr; 46(4):1107-11. PubMed ID: 8780100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA class II polymorphism in Latin American patients with multiple sclerosis.
    Rojas OL; Rojas-Villarraga A; Cruz-Tapias P; Sánchez JL; Suárez-Escudero JC; Patarroyo MA; Anaya JM
    Autoimmun Rev; 2010 Apr; 9(6):407-13. PubMed ID: 19896562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity to bee venom antigen phospholipase A2: association with specific HLA class I and class II alleles and haplotypes in beekeepers and allergic patients.
    Sánchez-Velasco P; Antón E; Muñoz D; Martínez-Quesada J; Ruíz de Alegría C; López-Hoyos M; García-Martín A; Jiménez I; Alonso ST; Duque S; Suárez A; Jerez J; Leyva-Cobián F
    Hum Immunol; 2005 Jul; 66(7):818-25. PubMed ID: 16112029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell receptor V genes in multiple sclerosis: increased use of TCRAV8 and TCRBV5 in MBP-specific clones.
    Offner H; Vandenbark AA
    Int Rev Immunol; 1999; 18(1-2):9-36. PubMed ID: 10614737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B.
    Jiang YG; Wang YM; Liu TH; Liu J
    World J Gastroenterol; 2003 Oct; 9(10):2221-5. PubMed ID: 14562382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes?
    Skarsvåg S; Hansen KE; Holst A; Moen T
    Tissue Antigens; 1992 Sep; 40(3):128-33. PubMed ID: 1440567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis.
    Castro F; Acevedo E; Ciusani E; Angulo JA; Wollheim FA; Sandberg-Wollheim M
    Ann Rheum Dis; 2001 Aug; 60(8):791-5. PubMed ID: 11454644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis. No differences from normal individuals and no relation to HLA-DR2.
    Zipp F; Faber E; Sommer N; Müller C; Dichgans J; Krammer PH; Martin R; Weller M
    J Neuroimmunol; 1998 Jan; 81(1-2):168-72. PubMed ID: 9521618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70-kd autoantibody positive connective tissue disease patients.
    Kaneoka H; Hsu KC; Takeda Y; Sharp GC; Hoffman RW
    Arthritis Rheum; 1992 Jan; 35(1):83-94. PubMed ID: 1370621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Could HLA-DRB1 be the protective locus in rheumatoid arthritis?
    Zanelli E; Gonzalez-Gay MA; David CS
    Immunol Today; 1995 Jun; 16(6):274-8. PubMed ID: 7544977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA class II (DRB1, DQA1 and DQB1) allele and haplotype frequencies among HIV-infection discordant Thai couples.
    Bejrachandra S; Kitayaporn D; Kaewkungwal J; Piya-Anant M; Permpikul P; Sirikong M; Siriboonrit U; Chandanayingyong D
    Asian Pac J Allergy Immunol; 2004; 22(2-3):143-51. PubMed ID: 15565951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A functional basis for the association of HLA class II genes and susceptibility to multiple sclerosis: cellular immune responses to myelin basic protein in a multiplex family.
    Voskuhl RR; Martin R; McFarland HF
    J Neuroimmunol; 1993 Feb; 42(2):199-207. PubMed ID: 7679119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB1*0701/2, -DQA1*0201, -DQB1*0303 extended haplotype.
    Schmitt-Egenolf M; Boehncke WH; Ständer M; Eiermann TH; Sterry W
    J Invest Dermatol; 1993 Jun; 100(6):749-52. PubMed ID: 8496614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DQA1, -DQB1 and -DRB1 genotyping in Japanese pemphigus vulgaris patients by the PCR-RFLP method.
    Niizeki H; Inoko H; Mizuki N; Inamoto N; Watababe K; Hashimoto T; Nishikawa T
    Tissue Antigens; 1994 Oct; 44(4):248-51. PubMed ID: 7871526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
    Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
    Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.